AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting riskPopularity #4,366

SKIN · NASDAQ · Medical - Specialties

SkinHealth Systems (SKIN)

Builds professional aesthetic treatments around devices and proprietary consumables.

$0.6734

After-hours close−0.00 (−0.27%)

At close$0.6752(+0.03%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	97	97	81	91	79	83	70	78	71	82	65	72
Cost of revenue	110	51	33	50	38	31	21	29	25	29	21	23
Gross profit	−13	46	48	41	41	52	49	49	46	53	44	49
	70	64	65	63	62	60	61	52	52	53	46	46
Research & development	2	3	3	1	1	1	1	1	2	2	1	1
	68	61	63	62	61	58	60	51	50	51	45	44
Selling & marketing	31	32	34	30	28	27	26	23	21	24	23	21
General & administrative	37	29	29	31	33	32	34	27	29	28	22	23
Operating income	−82	−18	−17	−22	−22	−7	−12	−3	−6	0	−2	4
	12	10	16	22	5	−5	3	21	−4	−5	−5	−5
Interest income	7	6	5	4	5	2	3	3	1	2	1	1
Interest expense	3	3	3	2	2	2	2	4	6	6	6	6
Other non-operating income	−15	−13	−19	−24	−8	2	−5	−26	−2	−1	−1	−1
Income before tax	−70	−9	−1	0	−16	−12	−9	19	−11	−5	−7	−1
Income tax expense	3	1	−1	0	2	−1	1	−1	0	3	0	1
Net income from continuing operations	−74	−9	−1	0	−18	−10	−10	20	−11	−8	−7	−3
Net income	−74	−9	−1	0	−18	−10	−10	20	−11	−8	−7	−3
EPS, basic	−$0.56	−$0.07	−$0.01	−$0.12	−$0.15	−$0.08	−$0.08	$0.15	−$0.09	−$0.06	−$0.05	−$0.02
EPS, diluted	−$0.56	−$0.07	−$0.10	−$0.10	−$0.15	−$0.08	−$0.08	$0.03	−$0.09	−$0.06	−$0.05	−$0.02
Weighted average shares, basic	133	129	123	124	124	124	125	126	127	127	128	130
Weighted average shares, diluted	133	129	144	142	124	124	125	140	127	127	131	130
EBITDA	−59	5	10	11	−4	−3	−1	28	4	7	5	13
Depreciation & amortization	8	10	9	9	10	7	6	5	8	5	5	8
EBIT	−67	−5	2	2	−14	−9	−7	23	−4	2	0	5